Banner

TOBY is advancing noninvasive cancer detection through urine-based volatile organic compound profiling, mass spectrometry, and artificial intelligence.

Research

3D colorful grid-like structure with varying heights, displaying a rainbow spectrum across its surface.

Text + image

<h1 style="white-space:pre-line">Featured Research</h1>
<h3>Duke-Led Prostate Cancer Study</h3>
<p>Preliminary findings using TOBY’s urine volatilomic technology were selected for podium presentation at the American Urological Association Annual Meeting and oral presentation at the Focal Therapy Society 2026 meeting.</p>
<p>The study explores AI-driven detection of low-PSA prostate cancer and MRI-invisible lesions.</p>
<h3>Conference Presentations</h3>
<p>AUA 2026 | Abstract ID: 26-7999</p>
<p>Focal Therapy Society 2026 | Abstract ID: FO2-6</p>
<p>Engineering and Urology Society 2026 | Poster #33</p>

Contact form

<h3>Be part of the movement for early detection via mass spectrometry of urine and artificial intelligence</h3>

name

email

I'm a

Patient

Healthcare Professional

Laboratory Professional

Investor

Other

message

TOBY

TOBY is a diagnostics platform using VOC analysis, spectroscopy, and AI to deliver early, noninvasive disease detection. Our first application, TOBY Oncology, is developing a simple urine test for early cancer detection.

Raleway

Cabin